Disclosed are methods of selective glandular pharmaco-ablation using compositions containing compounds based on small peptides and a pharmaceutically acceptable carrier. The methods of selectively destroying prostate gland overgrowth substantially or completely preserve key nerve, stromal, vascular, connective tissue, urethral musculature, and structural elements in intimate structural proximity to the foci of ablation.
